Greenspaces in communities are critical for mitigating effects of climate change and have important impacts on health. Today, the availability of satellite imagery data combined with deep learning methods allows for automated greenspace analysis at high resolution. We propose a novel green color augmentation for deep learning model training to better detect and delineate types of greenspace (trees, grass) with satellite imagery. Our method outperforms gold standard methods, which use vegetation indices, by 33.1% (accuracy) and 77.7% Intersection over Union (IoU). The proposed augmentation technique also shows improvement over state-of-the-art deep learning based methods by 13.4% (IoU) and 3.11% (accuracy) for greenspace segmentation. We apply the method to high-resolution (0.27 m /pixel) satellite images covering Karachi, Pakistan, and illuminate an important need; Karachi has 4.17 m2 of greenspace per capita, which significantly lags World Health Organization recommendations. Moreover, greenspaces in Karachi are often in areas of economic development (Pearson’s correlation coefficient shows a 0.352 correlation between greenspaces and roads, p < 0.001), and correspond to higher land surface temperature in localized areas. Our greenspace analysis and how it relates to infrastructure and climate is relevant to urban planners, public health and government professionals, and ultimately the public, for improved allocation and development of greenspaces.
1 October 2025 in BMJ Supportive & Palliative Care
Introduction Bone metastases (BMs) are a major cause of cancer-related pain. Palliative radiotherapy is effective for controlling these symptoms, but up to 40% of patients experience transient exacerbations of bone pain despite this. Glucocorticoids have been investigated for pain flare (PF) prophylaxis, but randomised controlled trials (RCTs) have yielded mixed results. The goal of this systematic review and meta-analysis was to analyse the pooled efficacy of glucocorticoids for PF prophylaxis after palliative radiotherapy to BMs. Methods The PubMed, EMBASE and Cochrane CENTRAL databases were systematically searched from inception until August 2024. RCTs that compared PF incidence after radiotherapy to BMs in patients who received prophylaxis with glucocorticoids versus placebo were included. Meta-analyses were conducted using a Mantel-Haenszel random effects model. Risk-of-bias was assessed using the Cochrane Risk of Bias 2 tool. Results We included four RCTs with a total of 765 patients. Three trials compared dexamethasone with placebo, while one trial compared methylprednisolone with placebo. Pooled analysis showed significantly reduced PF incidence after glucocorticoid prophylaxis (risk ratio: 0.59 (95% CI: 0.35 to 0.98), risk difference=−0.13 (95% CI: −0.24 to −0.02)). Study quality assessment indicated that two studies had a low risk of bias, while the other two had moderate and high risk, respectively. Conclusion Current randomised evidence supports the efficacy of glucocorticoid prophylaxis for the prevention of PFs in patients with BMs after the receipt of palliative radiation. Clinicians may consider this intervention to improve patient quality of life and symptom control.